Tech Company Financing Transactions

ArrePath Funding Round

On 3/4/2022, ArrePath announced $20 million in Seed funding from Boehringer Ingelheim Venture Fund, Innospark Ventures and Insight Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

303A College Rd. East
Princeton, NJ 08540
USA

Phone

(609) 423-1571

Website

www.arrepath.com

Email Address

Not Recorded

Overview

ArrePath was founded upon the mission to discover new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Lloyd Payne

        

VP - Engineering

Kurt Thorn

        

Browse more venture capital transactions:

Prev: 3/4/2022: SteadyPay venture capital transaction
Next: 3/4/2022: Visby Medical venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to document every notable VC transaction. All VC database entries on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary